Table 2.
Unit costs per person per year in 2007 US dollars for colorectal cancer treatment, by stage, phase of care, and treatment scenario, used as inputs for the MISCAN-Colon model*
| Terminal |
|||||
| Scenario | Stage | Initial | Continuous | Death from CRC | Death from other cause |
| Past | I | 24 472 | 2033 | 36 495 | 7361 |
| II | 31 878 | 2033 | 36 534 | 4849 | |
| III | 35 742 | 3727 | 38 485 | 7515 | |
| IV | 34 132 | 8809 | 37 288 | 12 906 | |
| Present | I | 28 668 | 2395 | 51 935 | 12 703 |
| II | 39 700 | 2237 | 51 712 | 11 035 | |
| III | 48 951 | 3249 | 54 776 | 14 708 | |
| IV | 64 801 | 10 419 | 73 522 | 39 679 | |
| Near future | I | 28 668 | 2395 | 111 935 | 12 703 |
| II | 39 700 | 2237 | 111 712 | 11 035 | |
| III | 79 801 | 3249 | 114 776 | 14 708 | |
| IV | 79 801 | 10 419 | 133 522 | 39 679 | |
Note: CRC, colorectal cancer
Costs for care were divided into three clinically relevant phases of care—initial, continuing, and terminal care. The initial phase was defined as the first 12 months following diagnosis, the terminal phase was defined as the final 12 months of life, and the continuing phase was defined as the period between the initial and terminal phases of care. The terminal care phase for colorectal cancer patients was further subdivided into terminal care preceding colorectal cancer death and terminal care preceding death from other causes. For patients surviving less than 24 months after diagnosis, the final 12 months of observation and costs of care were then allocated to the terminal phase. The remaining time was allocated to the initial phase, and no time was allocated to the continuing phase.